In a comparison of prostate carcinoma specimens and normal prostate samples at a threshold of at least a 2-fold change (P<0.01) (Figure 3B), RPL31 upregulation was observed in the study conducted by Tomlins and colleagues [35]. Here, RPL31 is linked to prostate carcinoma.